Emily Zabor, DrPH

I am an Assistant Staff in the Department of Quantitative Health Sciences and the Taussig Cancer Institute at Cleveland Clinic. Since earning my DrPH degree in biostatistics and starting my first faculty position in 2019, I have expanded my independent methodologic research program to focus on early phase oncology clinical trial design. I have proposed new statistical methodology for phase I expansion cohorts, randomized phase II trials, and basket trials, and have developed open-source software to allow for user-friendly implementation of the methods. In addition to methodologic development, I have worked as a collaborative cancer biostatistician for over 12 years, spanning numerous cancer types and applications. In this role, I have worked with numerous oncologists, surgeons, and other investigators to successfully collect and analyze data. I have experience working with data from clinical trials and observational studies (including retrospective databases) and have expertise in the selection and application of appropriate statistical methods. I have served as a co-investigator and statistician on a number of federally funded research projects. My collaborative efforts have resulted in over 100 publications in peer-reviewed journals. My success as both a collaborative and methodologic biostatistician has relied on my ability to complete analytic tasks thoroughly and on time, and to communicate effectively with others. My training in biostatistics, years of collaborative work, and recent methodologic developments related to early phase oncology trial design methodology make me ideal to lead the proposed project designed to develop novel statistical methodology for randomized dose ranging studies in oncology